midazolam HCl, 1 mg per mL (2 mg per 2 mL), in 0.9% Sodium Chloride, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3356.
Published October 19, 2016 · Recall initiated: July 17, 2015
Summary
FDA records drug Class II recall D-0075-2017, published October 19, 2016 and initiated July 17, 2015. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 26079 syringes; Lot: Lot Numbers: 151170045M, 151170084M, 151170093M, 15117084M, 151180080M, 15118092M, 15118094M, 15119054M, 15120072M, 15121093M, 151240093M, 151240094M, 151240099M, 15124074M, 151250094M, 15126044M, 15126079M, 15126080M, 15127097M, 15127098M, 15128112M, 151310092M, 151310103M, 151310105M, 15131028M, 151320099M, 15133012M, 15133081M, 15134068M,15134069M, 151380068M, 151380106M, 151380112M, 151390138M, 15139090M, 15140088M, 15140089M, 15141045M, 15141074M, 15141075M, 151450030M, 151450032M, 151460097M, 15146083M, 15146087M, 15149001M, 15149005M, 15149118M, 15149119M, 15150104M, 15152056M, 151720012M, 151730078M, 151730138M, 151740019M, 151740141M, 151740143M, 151890127M, 151890128M, 151890305M, 151900021M, 151900022M, 151900140M, 151930073M, 151930171M, 151930173M, Exp between 07/15/15-10/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- Nationwide
- Lot
- Lot Numbers: 151170045M, 151170084M, 151170093M, 15117084M, 151180080M, 15118092M, 15118094M, 15119054M, 15120072M, 15121093M, 151240093M, 151240094M, 151240099M, 15124074M, 151250094M, 15126044M, 15126079M, 15126080M, 15127097M, 15127098M, 15128112M, 151310092M, 151310103M, 151310105M, 15131028M, 151320099M, 15133012M, 15133081M, 15134068M,15134069M, 151380068M, 151380106M, 151380112M, 151390138M, 15139090M, 15140088M, 15140089M, 15141045M, 15141074M, 15141075M, 151450030M, 151450032M, 151460097M, 15146083M, 15146087M, 15149001M, 15149005M, 15149118M, 15149119M, 15150104M, 15152056M, 151720012M, 151730078M, 151730138M, 151740019M, 151740141M, 151740143M, 151890127M, 151890128M, 151890305M, 151900021M, 151900022M, 151900140M, 151930073M, 151930171M, 151930173M, Exp between 07/15/15-10/12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDAmidazolam HCl, 1 mg per mL (3 mg per 3 mL), in 0.9% Sodium Chloride, 3 mL Total Volume in a syringe, For IVOctober 19, 2016
- FDAmorphine Sulfate, 0.5 mg per mL, in 0.9% Sodium Chloride, Preservative Free (Contains Sulfites), 1 mL TotalOctober 19, 2016
Questions about this recall
Was midazolam HCl, 1 mg per mL (2 mg per 2 mL), in 0.9% Sodium Chloride, 2 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3356. recalled?
Yes. FDA published recall D-0075-2017 on October 19, 2016. Reported hazard: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail